Clinical Trial Update: Etanercept (Enbrel) in Undifferentiated Spondyloarthritis [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating etanercept (Enbrel) for undifferentiated spondyloarthritis, sponsored by Charite University in Berlin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondyloarthritis
• Undifferentiated Spondyloarthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Spondyloarthritis | Phase 2 | Status: UNKNOWN